Suppr超能文献

Buspirone in the treatment of tardive dyskinesia.

作者信息

Ross C A

出版信息

Med Hypotheses. 1987 Mar;22(3):321-8. doi: 10.1016/0306-9877(87)90197-6.

Abstract

Buspirone is a novel anxiolytic chemically unrelated to the benzodiazepines. In clinical trials it has been shown to be as effective as diazepam, with fewer side effects. Buspirone is primarily active in dopaminergic pathways. It has the properties of both a dopamine agonist and antagonist. In this paper a model for treatment of tardive dyskinesia with buspirone is developed, based on dopamine autoreceptor blockade. A clinical trial of buspirone in the treatment of movement disorders is warranted.

摘要

相似文献

1
Buspirone in the treatment of tardive dyskinesia.
Med Hypotheses. 1987 Mar;22(3):321-8. doi: 10.1016/0306-9877(87)90197-6.
2
[The use of buspirone in clinical practice].[丁螺环酮在临床实践中的应用]
Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(4):83-87. doi: 10.17116/jnevro20151154183-87.
3
Buspirone, Parkinson's disease, and the locus ceruleus.
Clin Neuropharmacol. 1986;9(4):373-8. doi: 10.1097/00002826-198608000-00004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验